UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
---------
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g)OF
THE SECURITIES EXCHANGE OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 1-11827
Trex Medical Corporation
------------------------
(Exact name of registrant as specified in its charter)
81 Wyman Street
P.O. Box 9046
Waltham, Massachusetts 02454-9046
(781) 622-1000
--------------
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
Common Stock, par value $.01 per share
---------------------------------------
(Title of each class of securities covered by this Form)
None
----
(Titles of all other classes of securities for which a duty to file
reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provisions
relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) ( ) Rule 12h-3(b)(1)(ii) ( )
Rule 12g-4(a)(1)(ii) ( ) Rule 12h-3(b)(2)(i) ( )
Rule 12g-4(a)(2)(i) ( ) Rule 12h-3(b)(2)(ii) ( )
Rule 12g-4(a)(2)(ii) ( ) Rule 15d-6 ( )
Rule 12h-3(b)(1)(i) (X)
Approximate number of holders of record as of the certification or notice date:
1
<PAGE>
Pursuant to the requirements of the Securities Exchange Act of 1934, Trex
Medical Corporation has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
Date: November 29, 2000 Trex Medical Corporation
By: /s/ William J. Webb
---------------------------------
Name: William J. Webb
Title: President and Chief Executive
Officer
